PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2021-07-15

Reporting Person: Dorval Allison (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-15	STOCK OPTION (RIGHT TO BUY)	$8.19	A	108721	Acquired	2031-07-14	COMMON STOCK (108721)	Direct

Footnotes

F1: The vesting commencement date of the option is July 15, 2021 (the "Option Vesting Commencement Date"). Subject to the Reporting Person's continued service with the Issuer through the applicable vesting date, the option vests (i) on the first anniversary of the Option Vesting Commencement Date with respect to one-third (1/3rd) of the shares subject thereto and (ii) on each monthly anniversary of the Option Vesting Commencement Date thereafter with respect to an additional 1/36th of the shares subject thereto.